The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khan, I. A.
Right arrow Articles by Kasper, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khan, I. A.
Right arrow Articles by Kasper, L. H.

The Journal of Immunology, Vol 147, Issue 10 3501-3506, Copyright © 1991 by American Association of Immunologists

ARTICLES

A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice

IA Khan, KH Ely and LH Kasper
Department of Medicine, Dartmouth Medical School, Hanover, NH 03756.

Induction of protective immunity against acute and chronic toxoplasmosis can be achieved using p30, the major membrane and excreted/secreted protein of Toxoplasma gondii. This protein, when administered to outbred mice in the presence of the saponin Quil A, is able to induce almost 100% protection against acute infection without evidence of intracerebral cyst development. Adoptive transfer of immune splenocytes from immunized inbred A/J mice conferred a significant level (p less than 0.001) of protection against subsequent challenge. Phenotypic analysis in outbred as well as two different strains of inbred mice (A/J and C57BL/6) demonstrated that CD8+ T cells are selectively stimulated by this immunization protocol. T cell depletion studies using specific mAb directed at either CD3+ or CD8+ T cell phenotype, followed by adoptive transfer, failed to confer protective immunity, whereas CD4+ depletion had no effect. These cytotoxic CD8+ T cells produced high titers of both IFN-gamma and IL-2. Moreover, these CD8+ T cells were directly parasiticidal against radiolabeled extracellular T. gondii, further supporting the critical immune function of these p30 Ag-specific CD8+ T cells in host immunity against T. gondii infection.


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
J. P. Gigley, B. A. Fox, and D. J. Bzik
Long-Term Immunity to Lethal Acute or Chronic Type II Toxoplasma gondii Infection Is Effectively Induced in Genetically Susceptible C57BL/6 Mice by Immunization with an Attenuated Type I Vaccine Strain
Infect. Immun., December 1, 2009; 77(12): 5380 - 5388.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
F. Lu, S. Huang, M. S. Hu, and L. H. Kasper
Experimental Ocular Toxoplasmosis in Genetically Susceptible and Resistant Mice
Infect. Immun., August 1, 2005; 73(8): 5160 - 5165.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
L. M. Staska, C. J. Davies, W. C. Brown, T. C. McGuire, C. E. Suarez, J. Y. Park, B. A. Mathison, J. R. Abbott, and T. V. Baszler
Identification of Vaccine Candidate Peptides in the NcSRS2 Surface Protein of Neospora caninum by Using CD4+ Cytotoxic T Lymphocytes and Gamma Interferon-Secreting T Lymphocytes of Infected Holstein Cattle
Infect. Immun., March 1, 2005; 73(3): 1321 - 1329.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M.-J. Gubbels, B. Striepen, N. Shastri, M. Turkoz, and E. A. Robey
Class I Major Histocompatibility Complex Presentation of Antigens That Escape from the Parasitophorous Vacuole of Toxoplasma gondii
Infect. Immun., February 1, 2005; 73(2): 703 - 711.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. K. Howe, R. Y. Gaji, M. Mroz-Barrett, M.-J. Gubbels, B. Striepen, and S. Stamper
Sarcocystis neurona Merozoites Express a Family of Immunogenic Surface Antigens That Are Orthologues of the Toxoplasma gondii Surface Antigens (SAGs) and SAG-Related Sequences
Infect. Immun., February 1, 2005; 73(2): 1023 - 1033.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
V. Letscher-Bru, A. W. Pfaff, A. Abou-Bacar, D. Filisetti, E. Antoni, O. Villard, J.-P. Klein, and E. Candolfi
Vaccination with Toxoplasma gondii SAG-1 Protein Is Protective against Congenital Toxoplasmosis in BALB/c Mice but Not in CBA/J Mice
Infect. Immun., November 1, 2003; 71(11): 6615 - 6619.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L.-Y. Kwok, S. Lutjen, S. Soltek, D. Soldati, D. Busch, M. Deckert, and D. Schluter
The Induction and Kinetics of Antigen-Specific CD8 T Cells Are Defined by the Stage Specificity and Compartmentalization of the Antigen in Murine Toxoplasmosis
J. Immunol., February 15, 2003; 170(4): 1949 - 1957.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. Bonenfant, I. Dimier-Poisson, F. Velge-Roussel, D. Buzoni-Gatel, G. Del Giudice, R. Rappuoli, and D. Bout
Intranasal Immunization with SAG1 and Nontoxic Mutant Heat-Labile Enterotoxins Protects Mice against Toxoplasma gondii
Infect. Immun., March 1, 2001; 69(3): 1605 - 1612.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. Haumont, L. Delhaye, L. Garcia, M. Jurado, P. Mazzu, V. Daminet, V. Verlant, A. Bollen, R. Biemans, and A. Jacquet
Protective Immunity against Congenital Toxoplasmosis with Recombinant SAG1 Protein in a Guinea Pig Model
Infect. Immun., September 1, 2000; 68(9): 4948 - 4953.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. Prigione, P. Facchetti, L. Lecordier, D. Deslee, S. Chiesa, M.-F. Cesbron-Delauw, and V. Pistoia
T Cell Clones Raised from Chronically Infected Healthy Humans by Stimulation with Toxoplasma gondii Excretory-Secretory Antigens Cross-React with Live Tachyzoites: Characterization of the Fine Antigenic Specificity of the Clones and Implications for Vaccine Development
J. Immunol., April 1, 2000; 164(7): 3741 - 3748.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
I. A. Khan, W. R. Green, L. H. Kasper, K. A. Green, and J. D. Schwartzman
Immune CD8+ T Cells Prevent Reactivation of Toxoplasma gondii Infection in the Immunocompromised Host
Infect. Immun., November 1, 1999; 67(11): 5869 - 5876.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. R. Radke and M. W. White
Expression of Herpes Simplex Virus Thymidine Kinase in Toxoplasma gondii Attenuates Tachyzoite Virulence in Mice
Infect. Immun., October 1, 1999; 67(10): 5292 - 5297.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. A. Khan, J. D. Schwartzman, L. H. Kasper, and M. Moretto
CD8+ CTLs Are Essential for Protective Immunity Against Encephalitozoon cuniculi Infection
J. Immunol., May 15, 1999; 162(10): 6086 - 6091.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. S. Hu, J. D. Schwartzman, G. R. Yeaman, J. Collins, R. Seguin, I. A. Khan, and L. H. Kasper
Fas-FasL Interaction Involved in Pathogenesis of Ocular Toxoplasmosis in Mice
Infect. Immun., February 1, 1999; 67(2): 928 - 935.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
E. Y. Denkers and R. T. Gazzinelli
Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection
Clin. Microbiol. Rev., October 1, 1998; 11(4): 569 - 588.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
I. Bourguin, M. Moser, D. Buzoni-Gatel, F. Tielemans, D. Bout, J. Urbain, and O. Leo
Murine Dendritic Cells Pulsed In Vitro with Toxoplasma gondii Antigens Induce Protective Immunity In Vivo
Infect. Immun., October 1, 1998; 66(10): 4867 - 4874.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. A. Khan, T. Matsuura, and L. H. Kasper
Inducible Nitric Oxide Synthase Is Not Required for Long-Term Vaccine-Based Immunity Against Toxoplasma gondii
J. Immunol., September 15, 1998; 161(6): 2994 - 3000.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
G. S. Yap, T. Scharton-Kersten, D. J. P. Ferguson, D. Howe, Y. Suzuki, and A. Sher
Partially Protective Vaccination Permits the Development of Latency in a Normally Virulent Strain of Toxoplasma gondii
Infect. Immun., September 1, 1998; 66(9): 4382 - 4388.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
V. Letscher-Bru, O. Villard, B. Risse, M. Zauke, J.-P. Klein, and T. T. Kien
Protective Effect of Vaccination with a Combination of Recombinant Surface Antigen 1 and Interleukin-12 against Toxoplasmosis in Mice
Infect. Immun., September 1, 1998; 66(9): 4503 - 4506.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
N. M. Silva, R. T. Gazzinelli, D. A. O. Silva, E. A. V. Ferro, L. H. Kasper, and J. R. Mineo
Expression of Toxoplasma gondii-Specific Heat Shock Protein 70 during In Vivo Conversion of Bradyzoites to Tachyzoites
Infect. Immun., August 1, 1998; 66(8): 3959 - 3963.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
I. D. Manger, A. B. Hehl, and J. C. Boothroyd
The Surface of Toxoplasma Tachyzoites Is Dominated by a Family of Glycosylphosphatidylinositol-Anchored Antigens Related to SAG1
Infect. Immun., May 1, 1998; 66(5): 2237 - 2244.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
F Seeber, J. Dubremetz, and J. Boothroyd
Analysis of Toxoplasma gondii stably transfected with a transmembrane variant of its major surface protein, SAG1
J. Cell Sci., January 1, 1998; 111(1): 23 - 29.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
I. J. Blader, I. D. Manger, and J. C. Boothroyd
Microarray Analysis Reveals Previously Unknown Changes in Toxoplasma gondii-infected Human Cells
J. Biol. Chem., June 22, 2001; 276(26): 24223 - 24231.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.